Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Jun 15;160(12):1719–1720.

Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program

G Atanackovic 1, G Koren 1
PMCID: PMC1230407  PMID: 10410634

Full Text

The Full Text of this article is available as a PDF (135.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Koren G., Feldman Y., Shear N. Motherisk--a new approach to antenatal counselling of drug/chemical exposure. Vet Hum Toxicol. 1986 Dec;28(6):563–565. [PubMed] [Google Scholar]
  2. Lammer E. J., Chen D. T., Hoar R. M., Agnish N. D., Benke P. J., Braun J. T., Curry C. J., Fernhoff P. M., Grix A. W., Jr, Lott I. T. Retinoic acid embryopathy. N Engl J Med. 1985 Oct 3;313(14):837–841. doi: 10.1056/NEJM198510033131401. [DOI] [PubMed] [Google Scholar]
  3. Mitchell A. A., Van Bennekom C. M., Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med. 1995 Jul 13;333(2):101–106. doi: 10.1056/NEJM199507133330206. [DOI] [PubMed] [Google Scholar]
  4. Pastuszak A., Koren G., Rieder M. J. Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate. Reprod Toxicol. 1994 Jan-Feb;8(1):63–68. doi: 10.1016/0890-6238(94)90068-x. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES